2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol

C65H73FN18O3 — CID 164951051

IUPAC2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol
SMILESCC(C)C1CCCN(c2ccc(-c3ncc(-c4cn[nH]c4)cc3O)nn2)C1.CC(C)[C@@H]1CCCN(c2ccc(-c3ncc(-c4cc(F)c5nn(C)cc5c4)cc3O)nn2)C1.Oc1cc(-c2cn[nH]c2)cnc1-c1ccc(N2CCCC(C3CC3)C2)nn1
InChIInChI=1S/C25H27FN6O.C20H22N6O.C20H24N6O/c1-15(2)16-5-4-8-32(14-16)23-7-6-21(28-29-23)25-22(33)11-18(12-27-25)17-9-19-13-31(3)30-24(19)20(26)10-17;27-18-8-15(16-10-22-23-11-16)9-21-20(18)17-5-6-19(25-24-17)26-7-1-2-14(12-26)13-3-4-13;1-13(2)14-4-3-7-26(12-14)19-6-5-17(24-25-19)20-18(27)8-15(9-21-20)16-10-22-23-11-16/h6-7,9-13,15-16,33H,4-5,8,14H2,1-3H3;5-6,8-11,13-14,27H,1-4,7,12H2,(H,22,23);5-6,8-11,13-14,27H,3-4,7,12H2,1-2H3,(H,22,23)/t16-;;/m1../s1
InChIKeyANMWJMLLPKAUPZ-GGMCWBHBSA-N
MW1173.42 g/mol
LogP11.58
Rot. Bonds12

About 2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol

2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol (PubChem CID 164951051) has the molecular formula C65H73FN18O3 and a molecular weight of 1173.42 g/mol. Its IUPAC name is 2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol.

Molecular Properties

Compound Name2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol
PubChem CID164951051
Molecular FormulaC65H73FN18O3
Molecular Weight1173.42 g/mol
Exact Mass1172.61
IUPAC Name2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol
SMILESCC(C)C1CCCN(c2ccc(-c3ncc(-c4cn[nH]c4)cc3O)nn2)C1.CC(C)[C@@H]1CCCN(c2ccc(-c3ncc(-c4cc(F)c5nn(C)cc5c4)cc3O)nn2)C1.Oc1cc(-c2cn[nH]c2)cnc1-c1ccc(N2CCCC(C3CC3)C2)nn1
InChIInChI=1S/C25H27FN6O.C20H22N6O.C20H24N6O/c1-15(2)16-5-4-8-32(14-16)23-7-6-21(28-29-23)25-22(33)11-18(12-27-25)17-9-19-13-31(3)30-24(19)20(26)10-17;27-18-8-15(16-10-22-23-11-16)9-21-20(18)17-5-6-19(25-24-17)26-7-1-2-14(12-26)13-3-4-13;1-13(2)14-4-3-7-26(12-14)19-6-5-17(24-25-19)20-18(27)8-15(9-21-20)16-10-22-23-11-16/h6-7,9-13,15-16,33H,4-5,8,14H2,1-3H3;5-6,8-11,13-14,27H,1-4,7,12H2,(H,22,23);5-6,8-11,13-14,27H,3-4,7,12H2,1-2H3,(H,22,23)/t16-;;/m1../s1
InChIKeyANMWJMLLPKAUPZ-GGMCWBHBSA-N
XLogP11.58
TPSA261.60 Ų
H-Bond Donors5
H-Bond Acceptors19
Rotatable Bonds12
Heavy Atoms87
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001173.42
LogP ≤ 511.58
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1019

Analyze 2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol?
The IUPAC name of 2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol (CID 164951051) is 2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol.
What is the SMILES notation for 2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol?
The canonical SMILES for 2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol is CC(C)C1CCCN(c2ccc(-c3ncc(-c4cn[nH]c4)cc3O)nn2)C1.CC(C)[C@@H]1CCCN(c2ccc(-c3ncc(-c4cc(F)c5nn(C)cc5c4)cc3O)nn2)C1.Oc1cc(-c2cn[nH]c2)cnc1-c1ccc(N2CCCC(C3CC3)C2)nn1.
What is the InChIKey of 2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol?
The InChIKey is ANMWJMLLPKAUPZ-GGMCWBHBSA-N. The full InChI is InChI=1S/C25H27FN6O.C20H22N6O.C20H24N6O/c1-15(2)16-5-4-8-32(14-16)23-7-6-21(28-29-23)25-22(33)11-18(12-27-25)17-9-19-13-31(3)30-24(19)20(26)10-17;27-18-8-15(16-10-22-23-11-16)9-21-20(18)17-5-6-19(25-24-17)26-7-1-2-14(12-26)13-3-4-13;1-13(2)14-4-3-7-26(12-14)19-6-5-17(24-25-19)20-18(27)8-15(9-21-20)16-10-22-23-11-16/h6-7,9-13,15-16,33H,4-5,8,14H2,1-3H3;5-6,8-11,13-14,27H,1-4,7,12H2,(H,22,23);5-6,8-11,13-14,27H,3-4,7,12H2,1-2H3,(H,22,23)/t16-;;/m1../s1.
What are the key properties of 2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol?
2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol has a molecular weight of 1173.42 g/mol, XLogP of 11.58, 12 rotatable bonds, 5 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-(3-cyclopropylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol;5-(7-fluoro-2-methylindazol-5-yl)-2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]pyridin-3-ol;2-[6-[(3S)-3-propan-2-ylpiperidin-1-yl]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol is sourced from PubChem (CID 164951051), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).